AstraZeneca colon cancer drug fails test

AstraZeneca

AstraZeneca PLC said Monday that its cancer drug Recentin failed in a head to head late stage trial with Roche AG’s Avastin in tests for use as an initial treatment against colon cancer.

The London-based drug company said it will wait for the results of a second study on Recentin — this time testing its effectiveness in combination with chemotherapy compared with chemotherapy alone — before deciding whether to submit the drug to regulators for marketing approval.

Read More :AstraZeneca colon cancer drug fails test

Related Youtube Video

[!] Report Abuse

Processing your request, Please wait....

Report as:	Invalid Contents Other
Write in Words: (Optional)

Short URL:http://www.usposttoday.com/?p=630

Posted by uspost on Mar 8 2010. Filed under Business, Health. You can follow any responses to this entry through the RSS 2.0. Both comments and pings are currently closed.